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The changes in blood viscosity, plasma viscosity, haematocrit and erythrocyte sedimentation rate before 
and during menstruation were evaluated. Forty (40) apparently healthy reproductive female subjects 
(between 15 and 28 years) and resident in Benin City, Edo State, Nigeria were used for the study. The 
parameters were analyzed using standard laboratory procedures and the data obtained were subjected to 
statistical analysis (paired t-Test; correlation and regression). Blood samples were collected during two 
phases of the menstrual cycle – the premenstrual and the mid menstrual phase. Results show variations in 
the studied parameters before and during menstruation. Relative blood viscosity, relative plasma viscosity 
and hematocrit were significantly reduced (P<0.001) during menstruation compared to the values before 
menstruation. The mean values of relative blood viscosity, relative plasma viscosity and hematocrit were 
2.52±0.07, 1.15±0.01 and 0.37±0.004L/L respectively for menstrual phase and 3.86±0.07, 1.49±0.02, 
0.43±0.005L/L respectively for premenstrual phase. Erythrocyte sedimentation rate (ESR) was significantly 
higher (6.78±0.18mm/hr) during the menstrual phase than during the premenstrual phase 
(4.61±0.10mm/hr) at P<0.001. Blood viscosity thus decreases during menstruation and this may be reduce 
the risk of cardiovascular diseases in premenopausal women. 
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INTRODUCTION 
Blood viscosity is a measurement of the thickness 
and stickiness of a person’s blood. Blood viscosity 
is a measure of the ability of blood to resist 
gradual deformation by shear or tensile stresses 
thereby leading to a resistance of blood to flow 
(Baskurt and Meiselman, 2003). Factors that 
affect blood viscosity includes; plasma viscosity, 
hematocrit, erythrocyte deformability, erythrocyte 
aggregation, and temperature. Menstruation is 
simply the periodic discharge of blood and 
mucosal tissue from the inner lining of the uterus 
through the vagina. This cyclic discharge is seen 
in females of certain mammalian species 
(including humans). It begins with the onset of 
menarche at or before sexual maturity and stops 
at or near menopause (commonly considered the  
end of a female's reproductive life). The periodicity 
of menstruation gives rise to commonly used 
euphemisms such as "period" and "monthly"  
(Logan and Carolyn, 1997). Profound physiologic 
changes occur in females during the monthly  
 
menstrual cycle. These include changes in blood 
pressure, variations in hematocrit, cyclic changes 
in thrombocyte count and white cell count. These 
changes are due to the effect of the female sex 
hormones: oestrogens and progesterone and the 
pituitary gonadotropins. These reported variations 
of vascular and hematologic parameters could 
possibly influence blood viscosity. Studies on 
haemorheological changes in black Africans are 
relatively scarce; this is especially with regard to 
changes during the menstrual cycle. Such studies 
are important to fully understand the possible role 
blood viscosity changes play in determining 
reported changes in blood pressure during the 
menstrual cycle (Reid andAnah, 1985). 
 
MATERIALS AND METHODS 
Subjects: A total of forty (40) females aged 
between 15 and 28 years with normal body mass 
index (BMI) were recruited into the study. They 
were selected by systematic random sampling 
from the female student population of about 400 at 
Simplex Academy lecture centre at Agbor park 
area, Benin City, Edo State, Nigeria. Each student 
gave informed consent and none had antecedent 
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history of cardiovascular or neurologic disease or 
condition. Cases of irregular periods, chronic 
disease and with history of drug affecting the 
menstrual cycle were not included.  Inclusion 
criterias includes females who had no 
cardiovascular disease or any other condition and 
only subjects with a normal menstruation cycles of 
30±3 days were recruited. They were physically 
examined and found apparently healthy. The forty 
healthy females were divided into two groups; 
premenstrual phase or Luteal phase which 
includes those expecting their “period” or menses 
and Menstrual phase (2nd – 4th day) which include 
those already menstruating. 
 
Blood Collection 
Each subject was allowed to rest comfortably for 
at least 20 minutes before blood collection. Five 
milliliters (5mls) of blood were collected using a 
hypodermal syringe from an antecubital vein with 
the subject comfortably seated and with minimum 
stasis. Blood sample was collected during the 
luteal phase (middle of luteal phase) and during 
menstruation. The blood was immediately 
transferred into an EDTA container. An aliquot of 
20ul from this sample was used for the 
determination of hematocrit. One milliliter was 
used for the measurement of relative whole blood 
viscosity, 2ml were used for erythrocyte 
sedimentation rate (ESR) determination and the 
remainder was centrifuged at 3000rpm for five 
minutes. The plasma was separated and used for 
the measurement of relative plasma viscosity.  All 
specimens were analyzed within three hours of 
collection to avoid diurnal variation. 
 
Methods 
Relative blood viscosity and relative plasma 
viscosity was determined by capillary viscometry 
using the single syringe method first described by 
Reid and Ugwu (1987) and modified by korobo- 
0wiye et al., (1997). Hematocrit was determined 
by the microhematocrit technique which involves 
the use of microcapillary tubes (Ochei and 
Kolhatkar, 2000). Erythrocyte Sedimentation Rate 
(ESR) was estimated by the method of 
Westergren (Dacie and Lewis, 1991).  
 
Statistical Analysis 
All values were expressed in mean ± standard 
error of mean. Data were analyzed using unpaired 
t-Test at p<0.001. Correlation and regression 
analysis was also done to show the relationship 
between the determinants of blood viscosity and 
plasma viscosity. Microsoft excel office package 
and SPSS were used. 
 
RESULTS AND DISCUSSION 
 
 
Table 1: Values of relative blood viscosity and its selected determinants during Premenstrual and Menstrual 











Relative Blood Viscosity  2.52±0.07 3.86±0.07 (p<0.001)  
Relative Plasma Viscosity 1.15±0.01 1.49±0.02 (p<0.001) 
Haematocrit (L/L) 0.37±0.004 0.43±0.005 (p<0.001) 
Erythrocyte sedimentation rate 
(mm/hr) 
6.78±0.18 4.61±0.10 (p<0.001) 









Figure 2: Regression analysis graph between erythrocyte sedimentation rate and haematocrit (p<0.001). 
 






Figure 3: Regression analysis graph between blood viscosity and plasma viscosity during menstrual phase 
(p<0.001). 
 
The results of the present study (Table 1) clearly 
indicate that blood viscosity and its determinants 
show significant (p<0.001) changes during the 
menstrual phase and premenstrual phase of the 
menstrual cycle. Interplay of several factors 
including the effect of menstruation and of the 
female sex hormones could possibly account for 
these changes in blood viscosity and its 
determinants. The results of this study have 
shown that some haemorheological profiles are 
altered at different phases of menstrual cycle. 
Hence, the present findings are in line with the 
report by Malini (2006), who studied 
haemorheological profiles in different phases of 
menstrual cycle in Bangalore, India. Low 
hematocrit values reported during the menstrual 
phase is likely due to blood loss that occurs at this 
phase of the cycle, leading to a reduction in red 
cell population. Low hematocrit during this phase 
is not fully explained by blood loss alone. Perhaps, 
changes in the concentration of hormones: 
oestrogen and progesterone during the menstrual 
cycle could contribute. There is usually a sudden 
drop in the levels of these female hormones 
during menstruation (Chiazzeet al., 1968). One of 
the functions of estrogen and progesterone is to 
maintain constant flow of blood to the uterus since 
they are vasodilators. It has been reported that 
estrogen promotes vasodilatation by stimulating 
the release of prostacyclin and nitric oxide and 
inhibiting the production of vasoconstrictors like 
Angiostensin II and endothelins (Rajnee et al., 
2010). A decrease in estrogen will thus decrease 
the constant flow of blood which leads to the 
rupture of the blood vessels and subsequent loss 
of blood from the body. Loss of blood will lead to a 
decrease in hematocrit (Speroh and Vande, 
1971). 
 
The relative whole blood viscosity (RWBV) 
showed a trend similar to that of hematocrit (Hct), 
being higher at the premenstrual phase and lower 
at the menstrual phase. Though several 
interdependent factors largely influence blood 
viscosity, hematocrit plays a primary role. Figure 1 
shows a highly significant (r= 0.67; p<0.000001) 
regression between blood viscosity and 
hematocrit. Blood viscosity regresses strongly on 
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hematocrit and it is thus a dependent variable. It 
therefore means that blood viscosity would largely 
decrease and increase along with hematocrit 
(Dacie and Lewis, 1991). A reduction in blood 
viscosity means increase blood flow through the 
body circulation, and this reduces the risk of 
hypertension. Premenopausal women have been 
reported to have a lower risk and incidence of 
hypertension and cardiovascular disease (CVD) 
compared to age-matched men and that this sex 
advantage for women gradually disappears after 
menopause, suggesting that sexual hormones 
play a cardio-protective role in women (Yang and 
Reckelhoff, 2011). 
 
The increase in erythrocyte sedimentation rate 
(ESR) in the menstrual phase is in line with the 
studies by Malini (2006) that ESR will fall faster 
due to decrease in hematocrit. Report by Dacie 
and Lewis, (1991) shows that polycythemic 
subjects will naturally have low ESR due to 
increase in erythrocyte aggregation (which forms a 
rouleaux) and reduced erythrocyte deformability 
which causes a slow fall in red blood cells. The 
regression analysis graph of Figure 2 shows a 
high significant regression (r=0.575; p<0.0001) 
between erythrocyte sedimentation rate and 
hematocrit. It is clear from the graph that ESR 
regresses inversely on hematocrit which means 
that ESR will likely decrease as hematocrit 
increases and vice versa. Thus, decrease in 
hematocrit could possibly account for the faster 
fall of red blood cells and hence increased ESR 
observed during menstruation (Everett et al., 
1978). Increase ESR during the menstrual phase 
could possibly explain decrease blood viscosity 
observed at this phase (Cheesbrough, 2000).    
 
Plasma viscosity was higher in premenstrual 
phase and lower in menstrual phase. The 
observed reduction in plasma viscosity is in line 
with the report by Kim et al. (1993) that mean 
values of hemoglobin, transferrin saturation and 
serum transferrin, were lowest during menses and 
highest in luteal or late luteal phase. Low 
transferrin can impair hemoglobin production since 
iron is needed to make hemoglobin (Crichton and 
Charloteaux-Wauters, 1987). It thus means that a 
low level of transferrin could lead to low level of 
hemoglobin which could result in decreased 
plasma viscosity observed during the menstrual 
phase (Macedo and De souse, 2008). Figure 3 
shows a very high significant (r= 0.748; p< 
0.00000001) regression of blood viscosity on 
plasma viscosity. Menstrual fluid which flows out 
of a reproductive female is composed of blood, old 
parts of uterine tissue, cells, mucin, bacteria 
making up the vagina flora, vagina secretions 
which contain water, and electrolytes such as 
sodium and potassium (Lentonet al., 1984). It also 
contains iron (fibrinogen), hemoglobin, proteins, 
platelets, cholesterol and bilirubin. Most of these 
substances are found in the blood plasma. It could 
thus be said that a loss in these substances from 
the plasma will help to keep plasma viscosity 
down. A decrease in relative plasma viscosity will 
likely explain the decrease in whole blood relative 
viscosity observed during the menstrual phase 
(Baker et al., 2001). 
 
CONCLUSION 
Since relative whole blood viscosity is lower during 
the menstrual phase and higher during the 
premenstrual phase of the menstrual cycle, it can 
thus be concluded that blood viscosity thus 
decreases during menstruation and this may be 
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